Barrett's esophagus (BE) is a premalignant condition associated with the development of
esophageal adenocarcinoma (EAC). Despite the low risk of progression to EAC, evidence …

Introduction: Esophageal adenocarcinoma (EAC) has a poor 5-year survival rate (10%–
18%), and incidence has increased dramatically in the past three decades. Barrett's …

Abstract Background and Aim: Although several molecular biomarkers for esophageal
adenocarcinoma (EAC) have been shown to be useful disease indicators, none has been …

Aims: To characterise a specific and sensitive marker of Barrett's metaplasia (BM). Methods:
Cases of normal oesophageal squamous mucosa (11 fresh endoscopic biopsies and 10 …

The incidence of esophageal adenocarcinoma has increased dramatically over recent years
and Barrett's esophagus is considered the most established risk factor for its development …

Introduction Barrett's esophagus (BE) is a premalignant condition associated with
esophageal adenocarcinoma (EAC). Evidence highlights that EAC is associated with an …

Introduction Barrett's esophagus (BO) is a pre-malignant condition for esophageal
adenocarcinoma (OAC), the incidence rate of which has risen dramatically over the last four …

Barrett's esophagus (BE) is a major risk factor for the development of esophageal
adenocarcinoma (EAC). BE patients undergo periodic endoscopic surveillance with …

Barrett's esophagus (BE) is one of the most common premalignant lesions and can progress
to esophageal adenocarcinoma. It is characterized histologically by a specialized intestinal …

In the current study we aimed to clarify the potential of EpCAM and villin as in vivo
biomarkers for both Barrett esophagus (BE)-associated neoplasia and BE versus cardiac …